Duke researchers study immune system response to chemotherapy for colorectal cancer
Read the story on the Duke Cancer Institute blog.
The Brain’s Blueprint Maker
Debra Silver, PhD, is pursuing one of neuroscience’s biggest questions: What makes a human brain human? She researches it with the same mix of precision and adventure she brings to her passion for scuba diving.
The DNA repair duo cancers use to build ecDNA — and gain an advantage
Duke University School of Medicine researchers have discovered the keys to survival for a circular form of DNA that drives many aggressive cancers.
Immune cells play key role in regulating eye pressure linked to glaucoma
New research from Duke reveals that a specialized set of immune cells known as resident macrophages are essential in maintaining healthy eye pressure, pointing to a promising new target for therapies to prevent a major cause of blindness.
New blood test signals who is most likely to live longer, study finds
Research led by Duke Health in collaboration with the University of Minnesota has found that small RNA molecules known as piRNAs can accurately predict whether older adults are likely to survive at least two more years.
The genes that help TB survive
Researchers at Duke and UNC-Chapel Hill have uncovered a set of bacterial survival genes activated only inside TB’s hard‑to‑study granulomas, revealing new clues to how the pathogen endures our immune defenses.
Leading at the Intersection of Technology and Care: A Conversation with Dr. Erik Sulman
In this conversation, Dr. Sulman reflects on what drew him to Duke, outlines his goals for strengthening Radiation Oncology’s clinical, research, and educational missions, and shares how innovation—from precision therapies to new technologies—is shaping the field.
New leaders, shared vision: Building community and opportunity across Duke
They may lead different employee resource groups (ERGs), but Magaly Guerrero and Antonio Jones share a similar vision for what belonging at Duke can look like. It’s a vision that will guide them as the newly named leaders of Duke University School of Medicine’s two ERGs.